Ambu A/S (OTCMKTS:AMBBY – Get Free Report) declared a dividend on Tuesday, November 5th, NASDAQ reports. Shareholders of record on Friday, December 6th will be paid a dividend of 0.0557 per share on Monday, December 23rd. The ex-dividend date of this dividend is Friday, December 6th.
Ambu A/S Stock Down 1.8 %
Ambu A/S stock opened at $17.12 on Thursday. The stock has a 50-day simple moving average of $19.02 and a 200-day simple moving average of $19.05. The company has a market capitalization of $4.02 billion and a P/E ratio of 71.33. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.51 and a current ratio of 2.52. Ambu A/S has a fifty-two week low of $12.65 and a fifty-two week high of $22.65.
Ambu A/S (OTCMKTS:AMBBY – Get Free Report) last issued its quarterly earnings data on Friday, August 30th. The company reported $0.07 earnings per share for the quarter. The company had revenue of $199.56 million during the quarter. Ambu A/S had a return on equity of 8.09% and a net margin of 8.55%.
Ambu A/S Company Profile
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
Featured Stories
- Five stocks we like better than Ambu A/S
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Monster Beverage Is a Scary Good Deal at Current Levels
- NYSE Stocks Give Investors a Variety of Quality OptionsÂ
- 2 Online Educational Platforms Staging a Turnaround
- 5 discounted opportunities for dividend growth investors
- Top 3 Sectors Outperforming After Trump’s Victory
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.